Biogen
Clinical trials sponsored by Biogen, explained in plain language.
-
MS drug trial for japanese patients halted early
Disease control TerminatedThis study tested a drug called natalizumab, given as a shot under the skin every 4 weeks, in Japanese adults with relapsing-remitting multiple sclerosis (MS). The goal was to see if it could reduce new brain lesions over 24 weeks. Only 21 people were enrolled, and the study was …
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 17, 2026 09:22 UTC
-
ALS drug trial halted: what happened with BIIB105?
Disease control TerminatedThis study tested an experimental drug, BIIB105, in adults with ALS, a disease that weakens muscles over time. The trial had two parts: first, some people got the drug and some got a placebo; then everyone could get the drug for up to 3 years. The main goals were to check safety …
Phase: PHASE1, PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated May 15, 2026 11:53 UTC